Literature DB >> 15967117

The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats.

Chengkai Dai1, Yelena Lyustikman, Alan Shih, Xiaoyi Hu, Gregory N Fuller, Marc Rosenblum, Eric C Holland.   

Abstract

Chronic platelet-derived growth factor (PDGF) signaling in glial progenitors leads to the formation of oligodendrogliomas in mice, whereas chronic combined Ras and Akt signaling leads to astrocytomas. Different histologies of these tumors imply that the pathways activated by these two oncogenic stimulations are different, and that the apparent lineage of the tumor cells may result from specific signaling activity. Therefore, we have investigated the signaling effects of PDGF in culture and in gliomas in vivo. In culture, PDGF transiently activates ERK1/2 and Akt, and subsequently elevates p21 and PCNA expression similar to chronic PDGF autocrine signaling in cultured astrocytes and PDGF-induced oligodendrogliomas in vivo. Culture experiments show that autocrine PDGF stimulation, and combined active Ras and Akt generate signaling patterns that are in some ways mutually exclusive. Furthermore, forced Akt activity in the context of chronic PDGF stimulation results in cells with an astrocytic differentiation pattern both in culture and in vivo. These data imply that these two interconvertible signaling motifs are distinct in mice and lead to gliomas resembling the two major glioma histologies found in humans. The ability of signaling activity to convert tumor cells from one lineage to another presents a mechanism for the development of tumors apparently comprised of cells from multiple lineages.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967117      PMCID: PMC1501153          DOI: 10.1593/neo.04691

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  35 in total

1.  A p53 and apoptotic independent role for p21waf1 in tumour response to radiation therapy.

Authors:  B G Wouters; N C Denko; A J Giaccia; J M Brown
Journal:  Oncogene       Date:  1999-11-11       Impact factor: 9.867

2.  A nestin-negative precursor cell from the adult mouse brain gives rise to neurons and glia.

Authors:  V G Kukekov; E D Laywell; L B Thomas; D A Steindler
Journal:  Glia       Date:  1997-12       Impact factor: 7.452

3.  p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation.

Authors:  R H Weiss; A Joo; C Randour
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

4.  Platelet-derived growth factor activates porcine thecal cell phosphatidylinositol-3-kinase-Akt/PKB and ras-extracellular signal-regulated kinase-1/2 kinase signaling pathways via the platelet-derived growth factor-beta receptor.

Authors:  C C Taylor
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

5.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

6.  PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

Authors:  J M Wood; G Bold; E Buchdunger; R Cozens; S Ferrari; J Frei; F Hofmann; J Mestan; H Mett; T O'Reilly; E Persohn; J Rösel; C Schnell; D Stover; A Theuer; H Towbin; F Wenger; K Woods-Cook; A Menrad; G Siemeister; M Schirner; K H Thierauch; M R Schneider; J Drevs; G Martiny-Baron; F Totzke
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

7.  Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.

Authors:  R S Morrison; F Yamaguchi; J M Bruner; M Tang; W McKeehan; M S Berger
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

8.  Molecular cloning of human p38 MAP kinase.

Authors:  J Han; B Richter; Z Li; V Kravchenko; R J Ulevitch
Journal:  Biochim Biophys Acta       Date:  1995-03-16

9.  Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction.

Authors:  B M Burgering; P J Coffer
Journal:  Nature       Date:  1995-08-17       Impact factor: 49.962

10.  ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation.

Authors:  H Gille; M Kortenjann; O Thomae; C Moomaw; C Slaughter; M H Cobb; P E Shaw
Journal:  EMBO J       Date:  1995-03-01       Impact factor: 11.598

View more
  19 in total

Review 1.  A review of the past, present, and future directions of neoplasia.

Authors:  Alnawaz Rehemtulla; Brian D Ross
Journal:  Neoplasia       Date:  2005-12       Impact factor: 5.715

2.  mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.

Authors:  Xiaoyi Hu; Pier Paolo Pandolfi; Yi Li; Jason A Koutcher; Marc Rosenblum; Eric C Holland
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

3.  Lentiviral-induced high-grade gliomas in rats: the effects of PDGFB, HRAS-G12V, AKT, and IDH1-R132H.

Authors:  John Lynes; Mia Wibowo; Carl Koschmann; Gregory J Baker; Vandana Saxena; A K M G Muhammad; Niyati Bondale; Julia Klein; Hikmat Assi; Andrew P Lieberman; Maria G Castro; Pedro R Lowenstein
Journal:  Neurotherapeutics       Date:  2014-07       Impact factor: 7.620

4.  Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

Authors:  Kurt A Jaeckle; S K Anderson; Erin L Twohy; Jesse G Dixon; Caterina Giannini; Robert Jenkins; Merrill J Egorin; Jann N Sarkaria; Paul D Brown; P J Flynn; John Schwerkoske; Jan C Buckner; Evanthia Galanis
Journal:  J Neurooncol       Date:  2019-05-22       Impact factor: 4.130

5.  Notch signaling enhances nestin expression in gliomas.

Authors:  Alan H Shih; Eric C Holland
Journal:  Neoplasia       Date:  2006-12       Impact factor: 5.715

6.  H-Ras increases urokinase expression and cell invasion in genetically modified human astrocytes through Ras/Raf/MEK signaling pathway.

Authors:  Yunge Zhao; Aizhen Xiao; Charles G Dipierro; Rana Abdel-Fattah; Samson Amos; Gerard T Redpath; Joan E Carpenter; Russell O Pieper; Isa M Hussaini
Journal:  Glia       Date:  2008-06       Impact factor: 7.452

7.  Spontaneous canine gliomas: overexpression of EGFR, PDGFRalpha and IGFBP2 demonstrated by tissue microarray immunophenotyping.

Authors:  Robert J Higgins; Peter J Dickinson; Richard A LeCouteur; Andrew W Bollen; Huamin Wang; Hua Wang; Linda J Corely; Lynnette M Moore; Wei Zang; Gregory N Fuller
Journal:  J Neurooncol       Date:  2009-12-05       Impact factor: 4.130

8.  PDGF-B-driven gliomagenesis can occur in the absence of the proteoglycan NG2.

Authors:  Marta Terrile; Irene Appolloni; Filippo Calzolari; Roberto Perris; Evelina Tutucci; Paolo Malatesta
Journal:  BMC Cancer       Date:  2010-10-12       Impact factor: 4.430

9.  Tumor progression and oncogene addiction in a PDGF-B-induced model of gliomagenesis.

Authors:  Filippo Calzolari; Irene Appolloni; Evelina Tutucci; Sara Caviglia; Marta Terrile; Giorgio Corte; Paolo Malatesta
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

10.  Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.

Authors:  Cameron Brennan; Hiroyuki Momota; Dolores Hambardzumyan; Tatsuya Ozawa; Adesh Tandon; Alicia Pedraza; Eric Holland
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.